Showing results (611-620 of 3,032) with videos related to

Sort By:
Pageof 304
International Journal of Clinical Pharmacology and Therapeutics|June 10, 2008
A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-DT Hawthorne, L Giot, L Blake, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 10, 2008
Clinical and social correlates with the use of depot antipsychotic drugs in outpatients with schizophrenia in ChinaY-T Xiang, Y-Z Weng, C-M Leung, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 11, 2008
Cutaneous pharmacokinetics of topically applied maxacalcitol ointment and lotionK Umemura, Y Ikeda, K Kondo, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 11, 2008
Symptomatic treatment of acute tonsillo-pharyngitis patients with a combination of Nigella sativa and Phyllanthus niruri extractM Dirjomuljono, I Kristyono, R R Tjandrawinata, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 27, 2016
Evaluation of the area under the curve of enteric-coated mycophenolate sodium using a limited sampling strategy in Chinese kidney transplant recipientsHongfeng Huang, Xi Yao, Jianyong Wu, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 15, 2016
CYP3A4*1G and CYP3A5*3 genetic polymorphisms alter the antihypertensive efficacy of amlodipine in patients with hypertension following renal transplantationYun Huang, Gaiyan Wen, Yao Lu, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 15, 2016
Utilization of population pharmacokinetics in drug development and provision of the results to healthcare professionalsMegumi Watanabe-Uchida, Mamoru Narukawa
International Journal of Clinical Pharmacology and Therapeutics|April 24, 2014
Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trialsKatrin Metzmann, David Schnell, Arvid Jungnik, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 24, 2014
Integrating disease progression models, non-clinical pharmacokinetic data and treatment response endpoints to optimize intravitreal dosing regimensAnthony S Basile, Theodore R Johnson, Karen J Klamerus, et al.
Pageof 304